Kesin is committed to developing a portfolio of strategic NDA505(b)(2) brand products to increase patient adherence and accessibility. Our technology-driven solutions support increased convenience, effectiveness, and persistence.
*Products pending FDA approval.
*Products pending FDA Approval.. The safety or effectiveness of the products has not been established.